dirucotide

DRUG3 trials

Sponsors

Eli Lilly and Company

Conditions

Relapsing Remitting Multiple SclerosisSecondary Progressive Multiple Sclerosis

Phase 2

A Study for Patients With Secondary Progressive Multiple Sclerosis

CompletedNCT00869726

Eli Lilly and CompanySecondary Progressive Multiple Sclerosis

Start: 2004-12-31End: 2009-05-31Updated: 2010-06-02

A Study for Patients With Relapsing Remitting Multiple Sclerosis

CompletedNCT00869986

Eli Lilly and CompanyRelapsing Remitting Multiple Sclerosis

Start: 2006-11-30End: 2009-09-30Updated: 2010-09-09

A Study for Patients With Multiple Sclerosis

TerminatedNCT00870155

Eli Lilly and CompanySecondary Progressive Multiple Sclerosis

Start: 2007-02-28End: 2009-09-30Target: 546Updated: 2010-09-09